PHGE
insider transactionsBiomX Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-6.7M
0 buy · 6.7M sell
Net value · 365d
-$33.3M
$0 in · $33.3M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
7
0 buy · 6.7M sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·C
Director, 10% Owner
$0
1.1K sh
Own New
-
Sell·S
Director, 10% Owner
$2.6M
530.0K sh · $5.00
Own -100%
-
Exercise·C
Director, 10% Owner
$1.1M
530.0K sh · $2.00
Own New
-
Sell·S
Director, 10% Owner
$8.1M
1.7M sh · $4.76
Own -100%
-
Sell·S
Director, 10% Owner
$10.5M
2.0M sh · $5.24
Own -54%
-
Sell·S
Director, 10% Owner
$6.5M
1.3M sh · $5.00
Own -39%
-
Exercise·C
Director, 10% Owner
$0
900 sh
Own +562%
-
Sell·S
Director, 10% Owner
$2.2M
450.0K sh · $5.00
Own -100%
-
Exercise·C
Director, 10% Owner
$900.0K
450.0K sh · $2.00
Own New
-
Exercise·C
Director, 10% Owner
$0
740 sh
Own +61%
-
Sell·S
Director, 10% Owner
$1.9M
370.0K sh · $5.00
Own -100%
-
Exercise·C
Director, 10% Owner
$740.0K
370.0K sh · $2.00
Own New
-
Exercise·C
Director, 10% Owner
$0
600 sh
Own +29%
-
Sell·S
Director, 10% Owner
$1.5M
300.0K sh · $5.00
Own -100%
-
Exercise·C
Director, 10% Owner
$600.0K
300.0K sh · $2.00
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Mar 17, 2026 | Reuven Yeganeh | Exercise C | 1.1K | $0 |
| Mar 17, 2026 | Reuven Yeganeh | Sell S | 530.0K | $2.6M |
| Mar 17, 2026 | Reuven Yeganeh | Exercise C | 530.0K | $1.1M |
| Mar 16, 2026 | Reuven Yeganeh | Sell S | 1.7M | $8.1M |
| Mar 16, 2026 | Reuven Yeganeh | Sell S | 2.0M | $10.5M |
| Mar 16, 2026 | Reuven Yeganeh | Sell S | 1.3M | $6.5M |
| Mar 16, 2026 | Reuven Yeganeh | Exercise C | 900 | $0 |
| Mar 16, 2026 | Reuven Yeganeh | Sell S | 450.0K | $2.2M |
| Mar 16, 2026 | Reuven Yeganeh | Exercise C | 450.0K | $900.0K |
| Mar 13, 2026 | Reuven Yeganeh | Exercise C | 740 | $0 |
| Mar 13, 2026 | Reuven Yeganeh | Sell S | 370.0K | $1.9M |
| Mar 13, 2026 | Reuven Yeganeh | Exercise C | 370.0K | $740.0K |
| Mar 12, 2026 | Reuven Yeganeh | Exercise C | 600 | $0 |
| Mar 12, 2026 | Reuven Yeganeh | Sell S | 300.0K | $1.5M |
| Mar 11, 2026 | Reuven Yeganeh | Exercise C | 300.0K | $600.0K |
About PHGE insider trading
This page tracks insider transactions for BiomX Inc. (PHGE) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.